Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Q fever vaccine in children aged 10 to 14 years
ACTRN12617000375358Phase 3Recruiting
- Sponsor
- The Children's Hospital at Westmead
- Start
- Jan 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Q-VAX in Q fever, sponsored by The Children's Hospital at Westmead. Primary endpoint: Safety and reactogenicity. Started Jan 2017; status: recruiting.
02
Drugs
Q-VAX
03
Conditions
Q fever
Beyond the preview
Go deeper on ACTRN12617000375358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000375358.